FDA Approves Xenoview for Use with MRI for the Evaluation of Lung Ventilation

MRI lungs
In Dec 2022, Xenoview™, a hyperpolarized contrast agent prepared from a proprietary Xenon 129Xe Gas Blend, received FDA approval

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: